Soldiers deployed to tropical and sunny climates are coming home with increased risk factors for a threat far from the battlefield: skin cancer.

A Vanderbilt lung cancer patient’s exceptional response to different types of therapies spurred research that suggests lung cancer patients with specific gene alterations may benefit from combination therapy that targets two different cancer pathways.

A subpopulation of bone cancer cells may be responsible for driving clinically aggressive behavior, suggesting new treatment options.

Vanderbilt researchers have identified a new target for blocking breast cancer metastasis.

Colorectal cancer is one of the leading causes of death among populations around the world. While diet, physical activity and other lifestyle factors can influence the risk of developing the disease, hereditary factors also play an important role.

Inhibition of BMP growth factor signaling reduces breast tumor burden and metastasis.

Vanderbilt researchers have found that selenium deficiency may contribute to the racial disparity in lung cancer incidence.